BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12854833)

  • 1. Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: core biopsy studies and clinical correlations.
    Corsi A; Collins MT; Riminucci M; Howell PG; Boyde A; Robey PG; Bianco P
    J Bone Miner Res; 2003 Jul; 18(7):1235-46. PubMed ID: 12854833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone.
    Bianco P; Riminucci M; Majolagbe A; Kuznetsov SA; Collins MT; Mankani MH; Corsi A; Bone HG; Wientroub S; Spiegel AM; Fisher LW; Robey PG
    J Bone Miner Res; 2000 Jan; 15(1):120-8. PubMed ID: 10646121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.
    Kobayashi K; Imanishi Y; Koshiyama H; Miyauchi A; Wakasa K; Kawata T; Goto H; Ohashi H; Koyano HM; Mochizuki R; Miki T; Inaba M; Nishizawa Y
    Life Sci; 2006 Apr; 78(20):2295-301. PubMed ID: 16337659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia.
    Collins MT; Chebli C; Jones J; Kushner H; Consugar M; Rinaldo P; Wientroub S; Bianco P; Robey PG
    J Bone Miner Res; 2001 May; 16(5):806-13. PubMed ID: 11341325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineralization in polyostotic fibrous dysplasia: histomorphometric analysis.
    Terpstra L; Rauch F; Plotkin H; Travers R; Glorieux FH
    J Bone Miner Res; 2002 Nov; 17(11):1949-53. PubMed ID: 12412801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormal expression of c-myc, p53, p16 protein and GNAS1 gene mutation in fibrous dysplasia].
    Tang J; Zhao HY; Zheng L; Zhang HZ; Jiang ZM
    Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):292-7. PubMed ID: 19575869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANKL Inhibition in Fibrous Dysplasia of Bone: A Preclinical Study in a Mouse Model of the Human Disease.
    Palmisano B; Spica E; Remoli C; Labella R; Di Filippo A; Donsante S; Bini F; Raimondo D; Marinozzi F; Boyde A; Robey P; Corsi A; Riminucci M
    J Bone Miner Res; 2019 Dec; 34(12):2171-2182. PubMed ID: 31295366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia.
    Stanton RP; Hobson GM; Montgomery BE; Moses PA; Smith-Kirwin SM; Funanage VL
    J Bone Miner Res; 1999 Jul; 14(7):1104-14. PubMed ID: 10404010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23.
    Imel EA; Econs MJ
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():434-9. PubMed ID: 17982392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry.
    Parfitt AM
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):387-403. PubMed ID: 12815335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.
    Robinson C; Collins MT; Boyce AM
    Curr Osteoporos Rep; 2016 Oct; 14(5):178-86. PubMed ID: 27492469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and molecular basis of fibrous dysplasia.
    Marie PJ
    Histol Histopathol; 2001 Jul; 16(3):981-8. PubMed ID: 11510989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone.
    Idowu BD; Al-Adnani M; O'Donnell P; Yu L; Odell E; Diss T; Gale RE; Flanagan AM
    Histopathology; 2007 May; 50(6):691-704. PubMed ID: 17493233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-Phenotype Correlation in Fibrous Dysplasia/McCune-Albright Syndrome.
    Zhadina M; Roszko KL; Geels RES; de Castro LF; Collins MT; Boyce AM
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1482-1490. PubMed ID: 33512531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of GNAS R201H substitution mutation in polyostotic fibrous dysplasia: Pyrosequencing analysis in tissue samples with or without decalcification.
    Shin SJ; Lee SJ; Kim SK
    Sci Rep; 2017 Jun; 7(1):2836. PubMed ID: 28588314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent demise of GNAS-mutated skeletal stem cells and "normalization" of fibrous dysplasia of bone.
    Kuznetsov SA; Cherman N; Riminucci M; Collins MT; Robey PG; Bianco P
    J Bone Miner Res; 2008 Nov; 23(11):1731-40. PubMed ID: 18597624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks.
    Riminucci M; Liu B; Corsi A; Shenker A; Spiegel AM; Robey PG; Bianco P
    J Pathol; 1999 Jan; 187(2):249-58. PubMed ID: 10365102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia.
    Collins MT; Singer FR; Eugster E
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S4. PubMed ID: 22640971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression.
    Riminucci M; Kuznetsov SA; Cherman N; Corsi A; Bianco P; Gehron Robey P
    Bone; 2003 Sep; 33(3):434-42. PubMed ID: 13678786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?
    Hannon TS; Noonan K; Steinmetz R; Eugster EA; Levine MA; Pescovitz OH
    J Pediatr; 2003 May; 142(5):532-8. PubMed ID: 12756386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.